CSI Singapore Principal Investigator, Prof. Wee Joo Chng has been awarded the NMRC Clinician Scientist – Individual Research Grant (CS-IRG) for a groundbreaking project:

🧬“The Role of Nutrient as a Driver of Oncogenic Transcriptional Program through the Metabolic-epigenetic Interplay in Multiple Myeloma”.

Prof. Chng Wee Joo, is a leading clinician-scientist and key opinion leader in the field of haematological malignancies, particularly Multiple Myeloma (MM). MM is the second most common hematological malignancy in Singapore and remains an incurable disease, particularly among elderly patients, despite the advent of novel therapeutic agents. Improved risk stratification and personalized treatment approaches require a deeper understanding of the molecular drivers underpinning MM.